Last reviewed · How we verify

NCT03268278: EBPEA

Efficacy of Buprenorphine on Postoperative Endodontic Analgesia

Terminated Phase 1 Last updated 23 April 2019
What this trial tests

Phase 1 trial testing Buprenorphine in Postoperative Pain in 10 participants. Terminated before completion.

Timeline
1 April 2017
Primary endpoint
1 July 2018
1 July 2018

Quick facts

Lead sponsorUniversity Hospitals Cleveland Medical Center
PhasePhase 1
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment10
Start date1 April 2017
Primary completion1 July 2018
Estimated completion1 July 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University Hospitals Cleveland Medical Center

Who can join

18 and older, any sex, with Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To see whether the addition of buprenorphone to local anesthesia will lengthen postoperative analgesia for endodontic pain

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Buprenorphine

Trials testing the same drug.

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other University Hospitals Cleveland Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03268278.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing